News | Stroke | January 15, 2024

Goldstein Selected to Help Lead Statewide Task Force Addressing Heart Disease and Stroke

Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology.

Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology. Photo by Shaun Ring.


January 15, 2024 — Larry Goldstein, M.D., chair of the University of Kentucky Department of Neurology, has been selected to serve as co-chair of The Kentucky Heart Disease and Stroke Prevention (KHDSP) Task Force representing stroke systems of care across the state. 

Goldstein is co-director of the Kentucky Neuroscience Institute, co-director of the UK Neuroscience Research Priority Area, contact PI for the state’s CDC Coverdell National Acute Stroke Program grant, and interim director of the UK-Norton Healthcare Stroke Care Network. Additionally, he also sits on the board of directors of The American Academy of Neurology (AAN)

With his focus on the stroke systems of care throughout Kentucky, Goldstein will lead the task force alongside Nathan Kusterer, M.D., a cardiologist with Baptist Health, who represents the state’s heart systems of care. 

The task force works in partnership with the Kentucky Department for Public Health’s Heart Disease and Stroke Prevention Program. The collaborative group was developed in 2006 to address cardiovascular disease in the Commonwealth. The task force is comprised of a diverse group of stakeholders committed to improving the health of Kentuckians. The initial membership included 27 individuals representing 14 agencies; the task force currently has 419 members representing 194 different agencies.

“Through our work on Kentucky's CDC Coverdell National Acute Stroke Program, I have been working with the KHDSP Task Force to advance stroke prevention and care throughout Kentucky,” said Goldstein. “This is another opportunity to coordinate and leverage efforts to reduce the burden of stroke statewide.”

The task force is represented by health systems, emergency medical organizations, community-based, professional and voluntary health organizations, businesses, higher level educational institutes and local and state government agencies. 

“The KHDSP brings together stroke and heart disease expertise and efforts to impact both conditions across the state.  It is a particularly important approach for improving public health by addressing commonalities between heart disease and stroke,” said Goldstein.

The goal of the Task Force is to improve Kentucky’s cardiovascular and cerebrovascular health. “It is wonderful to have the opportunity to lead and work with a group of passionate, dedicated colleagues focused on making our state healthier,” said Goldstein. 

For more information: https://www.uky.edu/


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now